1. Home
  2. LGVN vs JRSH Comparison

LGVN vs JRSH Comparison

Compare LGVN & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$1.04

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

HOLD

Current Price

$3.30

Market Cap

38.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGVN
JRSH
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
38.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
LGVN
JRSH
Price
$1.04
$3.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$4.00
AVG Volume (30 Days)
889.7K
52.2K
Earning Date
05-07-2026
02-09-2026
Dividend Yield
N/A
6.21%
EPS Growth
50.76
56.25
EPS
N/A
0.15
Revenue
$709,000.00
$145,812,006.00
Revenue This Year
N/A
$11.64
Revenue Next Year
$10.81
$10.06
P/E Ratio
N/A
$21.47
Revenue Growth
N/A
24.43
52 Week Low
$0.48
$2.82
52 Week High
$1.83
$3.60

Technical Indicators

Market Signals
Indicator
LGVN
JRSH
Relative Strength Index (RSI) 52.01 73.94
Support Level $0.69 $3.20
Resistance Level $1.23 $3.52
Average True Range (ATR) 0.10 0.10
MACD -0.02 0.04
Stochastic Oscillator 33.87 94.39

Price Performance

Historical Comparison
LGVN
JRSH

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: